| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10998688 | Veterinary Anaesthesia and Analgesia | 2014 | 6 Pages |
Abstract
The butorphanol dose (4 mg kgâ1) that produces clinically relevant sevoflurane MAC reduction in guineafowl caused severe adverse cardiopulmonary effects in two birds and was considered unsafe under the conditions used in this study.
Related Topics
Life Sciences
Agricultural and Biological Sciences
Animal Science and Zoology
Authors
André Escobar, Carlos AA Valadão, Robert J Brosnan, FabÃola N Flôres, Maristela CS Lopes, Fábio N Gava,